A clinical study on helminthic disorder in children with siddha drug

A clinical evaluation of Elisevikudineer a siddha drug in the treatment of Keerinoi (Threadworm -enterobius vermicularis) in children - Keerinoi

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/05/006934

Enrollment

Registered

2016-05-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Perianal itching Loss of appetite

Interventions

Intervention1: Yelisevi Kudineer: 80 ml, given orally once in a day for 3 days Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: Perianal itching Loss of appetite

Exclusion criteria

Exclusion criteria: Enteric fever Amoebiasis

Design outcomes

Primary

Measure	Time frame
Releiving of symptomsTimepoint: 3 days	—

Secondary

Measure	Time frame
Efficacy of the drugTimepoint: 14 days	—

Countries

India

Contacts

Public ContactVennila

National Institute of Siddha

drelamathi112@gmail.com9943788580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026